Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Shruti Naik
Research Interests
Explore related searches
Articles (5)
Year:
2026
Year:
2025
Year:
2025
Year:
2025
Mammalian cells autonomously activate hypoxia-inducible transcription factors (HIFs) to ensure survival in low-oxygen environments. We report here that injury-induced hypoxia is insufficient to trigger HIF1α in damaged epithelium. Instead, multimodal single-cell and spatial transcriptomics analyses and functional studies reveal that retinoic acid–related orphan receptor γt + (RORγt + ) γδ T cell–derived interleukin-17A (IL-17A) is necessary and sufficient to activate HIF1α. Protein kinase B (AKT) and extracellular signal–regulated kinase 1/2 (ERK1/2) signaling proximal of IL-17 receptor C (IL-17RC) activates mammalian target of rapamycin (mTOR) and consequently HIF1α. The IL-17A–HIF1α axis drives glycolysis in wound front epithelia. Epithelial-specific loss of IL-17RC, HIF1α, or blockade of glycolysis derails repair. Our findings underscore the coupling of inflammatory, metabolic, and migratory programs to expedite epithelial healing and illuminate the immune cell–derived inputs in cellular adaptation to hypoxic stress during repair.
Year:
2022
Collaborators (7)
Caleb Valencia
Stanford University
Michael T. Longaker
Professor
Stanford University
Kellen Chen
Assistant Research Professor
University of Arizona
William Shipman
Yale University School of Medicine
Silva Holtfreter
University Medicine Greifswald
Xuhui Zheng
University of Washington
Beatrix Ueberheide
Associate Professor
New York University
Make your next move.
Prepare your application
Review drafts before you send them.